Clinical Trial Update: Plasmodium Immunotherapy for Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on a plasmodium immunotherapy approach for lung cancer, currently in Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer

Snippet

Sponsor: State Key Laboratory of Respiratory Disease | Conditions: Lung Cancer, Nonsmall Cell | Phase 1, Phase 2 | Status: UNKNOWN